Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Merck and Company    MRK

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Latest Tweets
01:35p#ovariancancer AstraZeneca and Merck Rapidly Advance LYNPARZAÂ olaparib in Ja.. 
01:25pBRIEF-AstraZeneca and Merck advance LYNPARZA in Japan with a second regulator.. 
01:10pAstraZeneca and Merck Rapidly Advance LYNPARZA® (olaparib) in Japan With a Se.. 
01:02p$MRK $AZN AstraZeneca and Merck Rapidly Advance LYNPARZA® (olaparib) in Japan.. 
01:00pAstraZeneca and Merck Rapidly Advance LYNPARZA® (olaparib) in Japan With a Se.. 
12:56pMerck and : AstraZeneca and Merck Rapidly Advance LYNPARZA® (olaparib) in Jap.. 
12:48pWhat's next for #biopharma Q3 earnings
1
12:39p$MRK: Merck presents study data for ZEPATIER resulted in high rates of sustai.. 
12:19pIn new report, Steve Scala looks at how adjuvant use of immune oncology could.. 
11:51aGSK grabs FDA OK for new shingles vaccine, which will now tackle a key Merck ..
3
10:32aMerck & Company, Inc. $MRK Shares Sold by Shine Investment Advisory Servi.. 
08:35aBRIEF-AstraZeneca and Merck submit application for breast cancer drug in Japa.. 
10/22Seaward Management Limited Partnership Purchases 4,135 Shares of Merck & .. 
10/22Financial Advisory Service Inc. Increases Position in Merck & Company, In.. 
10/21Merck & Company's sell rating reiterated at Jefferies Group LLC. $55.00 P.. 
10/21Merck & Company Gets a Sell Rating from Jefferies $MRK  
10/21Merck & Company, Inc. $MRK Lifted to Buy at Citigroup Inc.  
10/21$MRK MN bull flag above 63.50 breakout level into earnings (Fri BMO) 
10/21$MRK Merck to cut 1,800 sales jobs, add 960 in chronic care  
10/21Davis R M Inc. Has $16.35 Million Holdings in Merck & Company, Inc. $MRK .. 
10/21Merck & Company, Inc. $MRK Holdings Lifted by Alley Co LLC  
10/21Merck to cut 1,800 U.S. sales jobs, add 960 in chronic care
6
10/21Merck to fire around 7% of its US staff  
10/21Merck plans to lay off about 1,800 U.S. sales representatives
69
10/21I reported Merck dumped potassium thiocyanate in Wissahickon Creek, it killed..
1
10/21Merck to cut 1,800 U.S. sales jobs, add 960 in chronic care
5
10/21Merck to lay off about 1,800 U.S. sales reps in cost-cutting move
1
10/21Merck to cut 1,800 U.S. sales jobs, add 960 in chronic care  
10/20Merck to cut 1,800 U.S. sales jobs, add 960 in chronic care
32
10/20Merck and : to Lay Off About 1,800 U.S. Sales Reps in Cost-Cutting Move  
10/20#Merck lays off 1,800 U.S. sales reps to overhaul #primarycare #marketing htt..
1
10/20Merck cuts 1,800 sales jobs nationwide, will add 960
1
10/20Merck cuts 1,800 sales jobs nationwide, will add 960
2
10/20Merck cuts 1,800 sales jobs nationwide, will add 960
1
10/20Pursuing Novel Pathways in Immunology: Merck KGaA, Darmstadt, Germany Present.. 
10/20UK regulator opens four new probes into generic drug competition..  
10/20Merck to cut 1,800 U.S. sales jobs, add 960 in chronic care
7
10/20Trending: $MRK plots 1,800 sales layoffs and a new chronic care team
2
10/20  
10/20REPORT: Merck to cut 1,800 jobs in sales reorganization:
2
10/20Merck to cut 1,800 U.S. sales jobs, add 960 in chronic care  
10/20Merck to cut 1,800 U.S. sales jobs, add 960 in chronic care
8
10/20Merck to cut 1,800 U.S. sales jobs, add 960 in chronic care
8
10/20Merck to cut 1,800 U.S. sales jobs, add 960 in chronic care  
10/20#Merck to cut 1,800 U.S. sales #jobs, add 960 in chronic care
1
10/20Merck to cut 1,800 U.S. sales jobs, add 960 in chronic care
19
10/20UPDATE 1-Merck to cut 1,800 U.S. sales jobs, add 960 in chronic care  
10/20Merck to cut 1,800 U.S. sales jobs, add 960 jobs in chronic care
8
10/20Merck to cut 1,800 U.S. sales jobs, add 960 in chronic care
1
10/20Merck to cut 1,800 U.S. sales jobs, add 960 in chronic care
2
More tweets
Qtime:342
Financials ($)
Sales 2017 40 270 M
EBIT 2017 13 680 M
Net income 2017 5 793 M
Debt 2017 8 103 M
Yield 2017 2,95%
P/E ratio 2017 31,87
P/E ratio 2018 19,03
EV / Sales 2017 4,53x
EV / Sales 2018 4,45x
Capitalization 174 B
Chart MERCK AND COMPANY
Duration : Period :
Merck and Company Technical Analysis Chart | MRK | US58933Y1055 | 4-Traders
Technical analysis trends MERCK AND COMPANY
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 70,0 $
Spread / Average Target 9,5%
EPS Revisions
Managers
NameTitle
Kenneth C. Frazier Chairman, President & Chief Executive Officer
Robert M. Davis CFO & Executive Vice President-Global Services
Clark Golestani Chief Information Officer & Executive VP
Thomas Henry Glocer Independent Director
Rochelle B. Lazarus Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MERCK AND COMPANY8.51%174 223
JOHNSON & JOHNSON23.60%382 202
NOVARTIS13.97%226 404
PFIZER12.13%216 886
ROCHE HOLDING LTD.0.77%207 116
AMGEN25.14%133 501